StockNews.com assumed coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Free Report) in a report released on Sunday. The brokerage issued a sell rating on the biotechnology company’s stock. Genocea Biosciences Stock Performance The company has a debt-to-equity ratio of 0.24, a current ratio of 1.35 and a quick ratio of 1.35. Genocea Biosciences has […]
StockNews.com started coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Get Free Report) in a research note issued to investors on Sunday. The brokerage set a “sell” rating on the biotechnology company’s stock. Genocea Biosciences Stock Performance The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of […]
Equities research analysts at StockNews.com began coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Get Free Report) in a report issued on Sunday. The brokerage set a “sell” rating on the biotechnology company’s stock. Genocea Biosciences Stock Performance The company has a market cap of $6,000.00, a price-to-earnings ratio of 0.00 and a beta of […]
StockNews.com began coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Free Report) in a report issued on Saturday morning. The brokerage issued a sell rating on the biotechnology company’s stock. Genocea Biosciences Stock Performance The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.24. Genocea Biosciences […]
Vericel (NASDAQ:VCEL – Get Free Report) and Genocea Biosciences (NASDAQ:GNCAQ – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, dividends and earnings. Analyst Recommendations This is a breakdown of recent ratings […]